中国医学创新Issue(16)：34-35,36,3.DOI:10.3969/j.issn.1674-4985.2013.16.016
紫杉醇联合化疗对中晚期胃癌的临床疗效观察及抗癌作用机制的探讨
The Mechanism and the Clinical Efficacy of Paclitaxel Combined with Chemotherapy in the Treatment of Advanced Gastric Cancer
许成贵1
作者信息
- 1. 山东省寿光市人民医院 山东 寿光 262700
- 折叠
摘要
Abstract
Objective:To explore the clinical efficacy of paclitaxel in the treatment of advanced gastric cancer and the mechanism.Method:68 cases of advanced gastric cancer were randomly divided into the observation group and the control group, the control group was given the PFL chemotherapy, the observation group was given paclitaxel on the basis of the control group, the clinical efficacy and safety of the two groups were observed. Result:The total efficiency of the control group was 38.2%,the total efficiency of the observation group was 61.8%,there were significant differences in the clinical efficacy of the groups(P<0.05).The adverse reactions of the two groups had no significant difference (P>0.05).Conclusion:The clinical efficacy of paclitaxel can significantly improve the treatment of advanced gastric cancer, the incidence of adverse reactions did not change.关键词
紫杉醇/中晚期胃癌/临床观察Key words
Paclitaxel/Advanced gastric cancer/Clinical observation引用本文复制引用
许成贵..紫杉醇联合化疗对中晚期胃癌的临床疗效观察及抗癌作用机制的探讨[J].中国医学创新,2013,(16):34-35,36,3.
